Income Statement (TTM)
Towa Pharmaceutical Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 129,674 | 141,230 | 154,900 | 159,927 | 162,514 | 165,262 | 165,615 | 168,060 | 173,861 | 180,407 | 208,859 | 218,035 | 225,755 | 236,779 | 227,934 | 235,952 | 243,942 | 253,346 | 259,594 | 262,177 |
| Change (%) | 8.91 | 9.68 | 3.25 | 1.62 | 1.69 | 0.21 | 1.48 | 3.45 | 3.77 | 15.77 | 4.39 | 3.54 | 4.88 | -3.74 | 3.52 | 3.39 | 3.86 | 2.47 | 1.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 73,834 | 81,602 | 89,448 | 92,124 | 93,011 | 94,131 | 95,429 | 99,455 | 105,878 | 112,935 | 136,145 | 141,979 | 147,975 | 154,708 | 146,551 | 151,235 | 155,886 | 161,628 | 164,865 | 167,116 |
| Change (%) | 10.52 | 9.61 | 2.99 | 0.96 | 1.20 | 1.38 | 4.22 | 6.46 | 6.67 | 20.55 | 4.29 | 4.22 | 4.55 | -5.27 | 3.20 | 3.08 | 3.68 | 2.00 | 1.37 | |
| % of Revenue | 56.94 | 57.78 | 57.75 | 57.60 | 57.23 | 56.96 | 57.62 | 59.18 | 60.90 | 62.60 | 65.19 | 65.12 | 65.55 | 65.34 | 64.30 | 64.10 | 63.90 | 63.80 | 63.51 | 63.74 |
| Gross Operating Profit | 55,840 | 59,628 | 65,452 | 67,803 | 69,503 | 71,131 | 70,186 | 68,605 | 67,983 | 67,472 | 72,714 | 76,056 | 77,780 | 82,071 | 81,383 | 84,717 | 88,056 | 91,718 | 94,729 | 95,061 |
| Change (%) | 6.78 | 9.77 | 3.59 | 2.51 | 2.34 | -1.33 | -2.25 | -0.91 | -0.75 | 7.77 | 4.60 | 2.27 | 5.52 | -0.84 | 4.10 | 3.94 | 4.16 | 3.28 | 0.35 | |
| % of Revenue | 43.06 | 42.22 | 42.25 | 42.40 | 42.77 | 43.04 | 42.38 | 40.82 | 39.10 | 37.40 | 34.81 | 34.88 | 34.45 | 34.66 | 35.70 | 35.90 | 36.10 | 36.20 | 36.49 | 36.26 |
| SG&A | 31,546 | 34,253 | 34,881 | 35,722 | 37,403 | 38,353 | 40,160 | 42,720 | 45,048 | 49,087 | 51,934 | 53,120 | 53,217 | 53,438 | 63,735 | 65,493 | 53,656 | 69,664 | 55,274 | 56,072 |
| Change (%) | 8.58 | 1.83 | 2.41 | 4.71 | 2.54 | 4.71 | 6.37 | 5.45 | 8.97 | 5.80 | 2.28 | 0.18 | 0.42 | 19.27 | 2.76 | -18.07 | 29.83 | -20.66 | 1.44 | |
| % of Revenue | 24.33 | 24.25 | 22.52 | 22.34 | 23.02 | 23.21 | 24.25 | 25.42 | 25.91 | 27.21 | 24.87 | 24.36 | 23.57 | 22.57 | 27.96 | 27.76 | 22.00 | 27.50 | 21.29 | 21.39 |
| R&D | 8,566 | 8,566 | 10,642 | 10,642 | 10,642 | 10,642 | 11,488 | 11,488 | 11,488 | 11,488 | 15,265 | 15,265 | 15,265 | 15,265 | 13,242 | 16,212 | 16,212 | |||
| Change (%) | 0.00 | 24.24 | 0.00 | 0.00 | 0.00 | 7.95 | 0.00 | 0.00 | 0.00 | 32.88 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| % of Revenue | 6.61 | 6.07 | 6.87 | 6.65 | 6.55 | 6.44 | 6.94 | 6.84 | 6.61 | 6.37 | 7.31 | 7.00 | 6.76 | 6.45 | 5.43 | 6.25 | 6.18 | |||
| OpEx | 113,946 | 124,421 | 134,971 | 138,488 | 141,056 | 143,126 | 147,077 | 153,663 | 162,414 | 173,510 | 203,344 | 210,364 | 216,457 | 223,411 | 210,286 | 216,728 | 222,784 | 231,292 | 236,351 | 239,400 |
| Change (%) | 9.19 | 8.48 | 2.61 | 1.85 | 1.47 | 2.76 | 4.48 | 5.69 | 6.83 | 17.19 | 3.45 | 2.90 | 3.21 | -5.87 | 3.06 | 2.79 | 3.82 | 2.19 | 1.29 | |
| % of Revenue | 87.87 | 88.10 | 87.13 | 86.59 | 86.80 | 86.61 | 88.81 | 91.43 | 93.42 | 96.18 | 97.36 | 96.48 | 95.88 | 94.35 | 92.26 | 91.85 | 91.33 | 91.29 | 91.05 | 91.31 |
| Operating Income | 15,728 | 16,809 | 19,929 | 21,439 | 21,458 | 22,136 | 18,538 | 14,397 | 11,447 | 6,897 | 5,515 | 7,671 | 9,298 | 13,368 | 17,648 | 19,224 | 21,158 | 22,054 | 23,243 | 22,777 |
| Change (%) | 6.87 | 18.56 | 7.58 | 0.09 | 3.16 | -16.25 | -22.34 | -20.49 | -39.75 | -20.04 | 39.09 | 21.21 | 43.77 | 32.02 | 8.93 | 10.06 | 4.23 | 5.39 | -2.00 | |
| % of Revenue | 12.13 | 11.90 | 12.87 | 13.41 | 13.20 | 13.39 | 11.19 | 8.57 | 6.58 | 3.82 | 2.64 | 3.52 | 4.12 | 5.65 | 7.74 | 8.15 | 8.67 | 8.71 | 8.95 | 8.69 |
| Interest Expense | -156 | -175 | -190 | -200 | -203 | -207 | -230 | -274 | -492 | -570 | -635 | -730 | -678 | -813 | -947 | -1,086 | -1,311 | -1,435 | -1,627 | -1,836 |
| Change (%) | 12.18 | 8.57 | 5.26 | 1.50 | 1.97 | 11.11 | 19.13 | 79.56 | 15.85 | 11.40 | 14.96 | -7.12 | 19.91 | 16.48 | 14.68 | 20.72 | 9.46 | 13.38 | 12.85 | |
| % of Revenue | -0.12 | -0.12 | -0.12 | -0.13 | -0.12 | -0.13 | -0.14 | -0.16 | -0.28 | -0.32 | -0.30 | -0.33 | -0.30 | -0.34 | -0.42 | -0.46 | -0.54 | -0.57 | -0.63 | -0.70 |
| Net Income | 13,688 | 12,981 | 13,958 | 15,934 | 16,949 | 19,511 | 15,914 | 11,998 | 9,364 | 2,898 | 2,201 | 5,556 | 6,462 | 11,735 | 16,173 | 16,918 | 15,775 | 19,279 | 18,986 | 16,004 |
| Change (%) | -5.17 | 7.53 | 14.16 | 6.37 | 15.12 | -18.44 | -24.61 | -21.95 | -69.05 | -24.05 | 152.43 | 16.31 | 81.60 | 37.82 | 4.61 | -6.76 | 22.21 | -1.52 | -15.71 | |
| % of Revenue | 10.56 | 9.19 | 9.01 | 9.96 | 10.43 | 11.81 | 9.61 | 7.14 | 5.39 | 1.61 | 1.05 | 2.55 | 2.86 | 4.96 | 7.10 | 7.17 | 6.47 | 7.61 | 7.31 | 6.10 |
Source: Capital IQ
